<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03990064</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A02182-53</org_study_id>
    <nct_id>NCT03990064</nct_id>
  </id_info>
  <brief_title>Benefits of Relaxation by Music Therapy on PTSD Symptoms</brief_title>
  <acronym>TRACER</acronym>
  <official_title>Exploration of Cerebral Metabolism and Connectivity in Post Traumatic Stress Disorder (PTSD): Exploratory Study of Neurofunctional Modulation of Emotions by Music Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Recherche Biomedicale des Armees</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Recherche Biomedicale des Armees</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PTSD is a debilitating mental disorder that may develop after experiencing or witnessing a
      life-threatening event. With appropriate care, treatment efficiency is variable and around
      20% of the patients do not respond to psychological treatment. Complementary treatments are
      needed.

      as PTSD implied autonomic nervous system (ANS) dysfonction, complementary treatment focusing
      on ANS regulation, as welle as musicotherapy, may have an interest.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim is to evaluate the impact of musicotherapy on PTSD symptoms, and severity using a RCT
      Symptoms will be evaluated using questionaires (PCL and quality of life) severity will be
      measured using neurological soft signs assessment, connectomic functions and ANS regulation
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>musicotherapy versus waiting list</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in PTSD symptoms</measure>
    <time_frame>change from PTSD symptoms at two months and at six months</time_frame>
    <description>questionnaire Posttraumatic CheckList 5 (PCL5; threshold =33)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in neurological soft signs</measure>
    <time_frame>change from neurological soft signs at two months and at six months</time_frame>
    <description>questionnaire EPSID &quot; Psychomotor assessment scale of neurological soft signs no threshold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in effective connectomic</measure>
    <time_frame>change from effective connectomic at two months and at six months</time_frame>
    <description>Magnetic Resonance Imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomous nervous system regulation</measure>
    <time_frame>change from Autonomous nervous system regulation at two months and at six months</time_frame>
    <description>heart rate variability during 5 min at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in biological stress</measure>
    <time_frame>change from biological stress at two months and at six months</time_frame>
    <description>blood cytokines, BDNF</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Stress Disorder, Post Traumatic</condition>
  <arm_group>
    <arm_group_label>musicotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>daily sessions of music listening during 2 months, associated with their standard treatment,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>waiting list</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>waiting list</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>musicotherapy</intervention_name>
    <description>receptive music therapy. The musical style of the session was chosen by the patient. The validated 'U' technique was employed.</description>
    <arm_group_label>musicotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PTSD

        Exclusion Criteria:

          -  neurological diseases

          -  addiction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 8, 2019</study_first_submitted>
  <study_first_submitted_qc>June 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2019</study_first_posted>
  <last_update_submitted>June 15, 2019</last_update_submitted>
  <last_update_submitted_qc>June 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut de Recherche Biomedicale des Armees</investigator_affiliation>
    <investigator_full_name>Marion Trousselard</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>effective connectomic neurological soft signs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

